期刊文献+

3.0T MR弥散加权成像在肾脏肿块型病变中的诊断价值 被引量:3

MR diffusion weighted imaging in diagnosis and differential diagnosis of renal masses
下载PDF
导出
摘要 目的评价3.0T MR弥散加权成像(diffusion weighted imaging,DWI)序列在肾脏肿块型病变的诊断及鉴别诊断价值。方法回顾性分析152例肾脏肿块型病变,采用3.0T MR行b值=800 s/mm2DWI检查,除肾囊肿(包括单纯囊肿及复杂囊肿)外,所有肿瘤均经手术病理或穿刺活检证实,对病灶的DWI信号特点进行记录和分析,计算DWI诊断肾脏良恶性肿瘤的灵敏度、特异度、阳性预测值、阴性预测值,比较所有病灶的ADC值。结果与癌周组织相比,肾细胞癌表观弥散系数(apparent diffusion doefficient,ADC)值差异有统计学意义(P<0.05);与非透明细胞癌相比,肾透明细胞癌ADC差异有统计学意义(P<0.05)。肾细胞癌、肾盂癌、肾脓肿、肾血管平滑肌脂肪瘤、肾囊肿及肾细胞癌囊变区各组ADC值差异有统计学意义(F=129.71,P=0.000),其中肾细胞癌、肾血管平滑肌脂肪瘤及肾盂癌组的ADC值两两之间差异有统计学意义(P<0.01),肾细胞癌及肾盂癌的ADC值统计学上均低于良性病变(肾脓肿及肾血管平滑肌脂肪瘤),肾盂癌的ADC值最低,肾血管平滑肌脂肪瘤的ADC值最高。良性囊肿性病变及肾细胞癌囊变区的ADC值差异有统计学意义(t=3.756,P=0.000)。其中透明细胞癌临床各分期两两比较发现,Ⅰ期与Ⅲ、Ⅳ期及Ⅱ期与Ⅲ、Ⅳ期相比,差异有统计学意义(P<0.01),Ⅲ期及Ⅳ期的ADC值较低。结论高b值DWI鉴别肾脏良恶性肿瘤有较高的准确率,结合量化分析ADC值能够更好的显示肾脏肿块的病变特征,在肾脏肿块的鉴别以及恶性程度评估等方面有着重要的意义。 Objective To evaluate the application of 3. 0 T MR diffusion weighted imaging( DWI)in diagnosis and differential diagnosis of renal masses. Methods The images of 152 patients with renal masses receiving MR DWI scans with b value = 0,800 s / mm^2 with a 3. 0T scanner were analyzed retrospectively. All masses were confirmed by pathology except for renal cysts( including simple and complex cysts). The sensitivity,specificity,accurate rate,positive predictive value and negative predictive value of ADC values in differentiating benign from malignant tumors and DWI features of all lesions were analyzed. Results There were significant differences in ADC values between renal cell carcinoma and peritumoral tissues,between renal clear cell carcinoma and non-clear carcinoma. LSD test showed that there were significant differences in ADC values among renal cell carcinoma,renal angiomyolipoma and carcinoma of renal pelvis( P〈 0. 01). ADC values of renal cell carcinoma and carcinoma of renal pelvis were significantly different from benign tumors( P 〈0. 01),renal pelvis carcinoma had the lowest ADC value and renal angiomyolipoma had the highest value. The ADC values of benign renal cystic lesions and cystoid variation in renal cell carcinoma were significant different. LSD test showed that there were significant differences in ADC values between phase I and Ⅲ/Ⅳ,phase ⅡandⅢ/Ⅳ( P 〈0. 01); and phase Ⅲ and Ⅳ had the lowest ADC value. Conclusion The results shows that DWI has high accuracy rate for differentiating benign from malignant urothelial carcinoma with high b value. The quantitative analysis of ADC value can showthe lesions more accurately,and may be of value in differential diagnosis of malignant from benign lesions and the evaluation of malignant degrees.
出处 《同济大学学报(医学版)》 CAS 2016年第1期51-55,共5页 Journal of Tongji University(Medical Science)
关键词 弥散加权成像 表观弥散系数 肾脏肿块 鉴别诊断 diffusion weighted imaging apparent diffusion coefficient value renal masses differential diagnosis
  • 相关文献

参考文献15

  • 1Sandrasegaran K, Sundaram CP, Ramaswamy R, et al. Usefulnes of diffusion-weighted imaging in the evaluation of renal masses [ J ]. AJR Am J Roentgenol, 2010,194(2) : 438-445.
  • 2姚秀忠,刘豪,陈文芳,曾蒙苏.3.0T磁共振自由呼吸背景抑制弥散加权成像对胰腺肿块的诊断价值[J].中国临床医学,2013,20(1):64-66. 被引量:12
  • 3Yamashita Y, Kumabe T, Higano S, et al. Minimum apparent diffusion coefficient is significantly correlated with cellularity in meduUoblastomas [ J ]. Neurol Res, 2009,31(9) : 940-946.
  • 4Zhang YL, Yu BL, Ren J, et al. EADC values in diagnosis of renal lesions by 3.0 T diffusi-on-weighted magnetic resonance imaging: compared with the ADC values [J ], Appl Magn Resort, 2013,44 ( 3 ) 349 - 363.
  • 5Sandrasegaran K, Sundaram CP, Ramaswamy R,et al. Useful-ness of diffusion-weighted imaging in the evaluation of renal masses [J ]. A JR Am J Roentgenol, 2010,194(2) 438-445.
  • 6Inci E, Hocaoglu E, Aydin S, et al. Diffusion-weig- hted magnetic resonance imaging in evaluation of primary solid and cystic renal masses using the Bosniak classification[ J ]. Eur J Radiol, 2012,81 ( 5 ) : 815 - 820.
  • 7Chong Y, Kim CK, Park SY, et al. Value of diffusion-weighted imaging at 3 T for prediction of extracapsular extension in patients with prostate cancer: a preliminary study[J]. AIR Am J Roentgenol,2014, 202 (4) : 772 - 777.
  • 8Kobayashi S, Koga F, Yoshida S, et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: diffusion coefficient values clinical aggressiveness[ J]. 2178 - 2186. potential utility of apparent as a biomarker to predict Eur Radiol,2011,21 (10) :.
  • 9Muhi A, Ichikawa T, Motosugi U, et al. High-b-value diffusion-weighted MR imaging of hepatocellular le- sions: estimation of grade of malig-nancy of he- patocellular carcinoma [ J]. J Magn Reson Imaging, 2009,30(5) : 1005 - 1011.
  • 10Yu X, Lin M, Ouyang HA, et al. Application of ADC measurement in characterization of renal cell car- cinomas with different pathological types and grades by 3.0 T diffusion-weighted MRI [ J ]. Eur J Radiol, 2012,81 ( 11 ) 3061 - 3066.

二级参考文献13

  • 1Matsuki M,Inada Y, Nakai G,et al. Diffusion-weighed MRimaging of pancreatic carcinoma[J]. Abdom Imaging,2007. 32.4):481-483.
  • 2Lee SS, Byun JH, Park BJ,et al. Quantitative analysis of dif-fusion-weighted magnetic resonance imaging of the pancreas:usefulness in characterizing solid pancreatic masses [J]. JMagn Reson Imaging. 2008, 28(4) :928-936.
  • 3Lichy MP, Aschoff P,Plathow C,et al. Tumor detection bydiffusion-weighted MRI and ADC-mapping—initial clinical ex-periences in comparison to PET-CT[J]. Invest Radiol, 2007,42(9):605-613.
  • 4Muraoka N,Uematsu H,Kimura H,et al. Apparent diffu-sion coefficient in pancreatic cancer characterization and his-topathological correlations[J], J Magn Reson Imaging. 2008,27C6):1302-130B.
  • 5Fattahi R, Balci NC, Perman WH,et al. Pancreatic diffusion-weighted imaging (DWD : comparison between mass-formingfocal pancreatitis (FP),pancreatic cancer (PC),and normalpancreas[J]. J Magn Reson Imaging, 2009,29(2):350-356.
  • 6Shrikhande SV, Barreto SG,Goel M, et al. Multimodalityimaging of pancreatic ductal adenocarcinoma : a review of theliterature[J]. HPB (Oxford) ,2012,14(10) :658-668.
  • 7Cwik G,Wallner G,Skoczylas T, et al. Cancer antigens 19-9and 125 in the differential diagnosis of pancreatic mass lesions[J]. Arch Surg,2006, 141 (10) :968-973; discussion 974.
  • 8LamJS, Shvart 0,Pantack AJ. Changing concepts in the surgical man-agement of renal cell carcinoma [ J ]. Eur Urol,2004,45 ( 3 ) : 692 -705.
  • 9Kirkali Z, Ober C. Clinical aspects of renal cell carcinoma[ J]. EAUUpdate Series,2003,1 (2) :189 -196.
  • 10CovaM,Squillaci E’Stacul F,et al. Diffusion-weighted MRI in the e-valuation of renal lesions :preliminary results[ J]. Br J Radiol,2004,77 (922) :851 -857.

共引文献17

同被引文献39

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部